Sansure BiotechSHSE:688289 +0.47%62 Forward Dividend Yield % is 3.48% as of Jul. 03, 2026. GuruFocus rates SHSE:688289 with a GF Score™ of 62/100 and a GF Value™ of ¥20.63 (Modestly Undervalued). The stock has 7 warning signs investors should review. Among 315 Medical Devices & Instruments companies, Sansure Biotech ranks better than 72.06% on this metric.
As of today (2026-07-03), the Forward Annual Dividend Yield of Sansure Biotech is 3.48%.
As of today (2026-07-03), the Trailing Annual Dividend Yield of Sansure Biotech is 3.48%.
SHSE:688289's Forward Dividend Yield % is ranked better than 72.06% of 315
companies
in the Medical Devices & Instruments industry
Industry Median: 2.03
vs SHSE:688289: 3.48
During the past 12 months, Sansure Biotech's average Dividends Per Share Growth Rate was 19.30% per year.
During the past 3 years, the average Dividends Per Share Growth Rate was -24.30% per year.
During the past 5 years, the average Dividends Per Share Growth Rate was -5.20% per year.
During the past 9 years, the highest 3-Year average Dividends Per Share Growth Rate of Sansure Biotech was 11.30% per year. The lowest was -24.30% per year. And the median was -16.00% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
Sansure Biotech Forward Dividend Yield % Related Terms
SHSE:688289 vs ISRG, BDX, MDLN: Forward Dividend Yield % Comparison
For the Medical Instruments & Supplies subindustry, Sansure Biotech's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sansure Biotech Forward Dividend Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Sansure Biotech's Forward Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Sansure Biotech's Forward Dividend Yield % falls into.
Dividend Yield measures how much a company pays out in dividends each year relative to its share price.
Sansure Biotech Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
CNY 0.261000
2026-06-22
2026-06-18
2026-06-22
Cash Dividend
semi-annually
CNY:CNY 1.000000
CNY 0.262000
2025-09-23
2025-09-22
2025-09-23
Cash Dividend
semi-annually
CNY:CNY 1.000000
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
Sansure Biotech's Forward Annual Dividend Yield (%) for Today is calculated as
Forward Annual Dividend Yield
=
Forward Full Year Dividend
/
Current Share Price
=
0.522
/
15.12
=
3.45 %
Current Share Price is ¥15.12. Sansure Biotech's Dividends per Share for the forward twelve months is calculated as ¥0.261 * 2 = ¥0.522.
Sansure Biotech's Trailing Annual Dividend Yield (%) for Today is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Forward Dividend Yield % of 3.48% mean?
Sansure Biotech (SHSE:688289) has a Forward Dividend Yield % of 3.48% as of Jul. 03, 2026. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Sansure Biotech and its competitors. According to the industry distribution chart, Sansure Biotech ranks #88 out of 315 companies in the Medical Devices & Instruments industry, placing it in the top 27.9%.
Is Sansure Biotech's Forward Dividend Yield % too high?
Sansure Biotech's current Forward Dividend Yield % is 3.48%. The Medical Devices & Instruments industry median Forward Dividend Yield % is 2.03. Sansure Biotech's value of 3.48% is 71.4% above this industry median. Based on the distribution chart, Sansure Biotech ranks #88 out of 315 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Sansure Biotech has a GF Score™ of 62/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Sansure Biotech's Forward Dividend Yield % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Sansure Biotech ranks #88 out of 315 companies for Forward Dividend Yield %. This puts Sansure Biotech in the upper half of its industry. The industry median Forward Dividend Yield % is 2.03. Sansure Biotech's value of 3.48% is 71.4% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward Dividend Yield % for a Medical Devices & Instruments company?
The median Forward Dividend Yield % among Medical Devices & Instruments companies is 2.03, based on 315 companies in the industry. Companies in the top quartile (top 25%) have a Forward Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Forward Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sansure Biotech's current Forward Dividend Yield % of 3.48% is 71.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward Dividend Yield % mean?
A high Forward Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Sansure Biotech and its competitors. For the Medical Devices & Instruments industry, the median Forward Dividend Yield % is 2.03 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sansure Biotech's current Forward Dividend Yield % is 3.48%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sansure Biotech stock overvalued right now?
Based on GuruFocus' analysis, Sansure Biotech (SHSE:688289) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥20.63, compared to a current price of ¥15.12 — trading 26.7% below its estimated fair value. The current Forward Dividend Yield % is 3.48% and 71.4% above the Medical Devices & Instruments industry median of 2.03. Sansure Biotech's overall GF Score™ is 62/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward Dividend Yield % calculated?
Forward Dividend Yield % is calculated from a company's financial statements. For Sansure Biotech (SHSE:688289), the current Forward Dividend Yield % is 3.48% as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sansure Biotech (SHSE:688289) Overvalued in 2026?
Based on GuruFocus' analysis, Sansure Biotech stock appears to be undervalued.
The current stock price of ¥15.12 is trading 26.7% below its estimated GF Value™ of ¥20.63.
GuruFocus considers Sansure Biotech to be Modestly Undervalued.
Key valuation signals for SHSE:688289:
Forward Dividend Yield %: 3.48%
GF Value™: ¥20.63 vs. price of ¥15.12 (26.7% below fair value)
Industry Position: 71.4% above the Medical Devices & Instruments median (#88 of 315)
No single metric tells the full story. See the SHSE:688289 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688289 has been successfully added to your 